Allogeneic HSCT: Clinical Trials

2 trials of Allogeneic HSCT, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1

Follow Allogeneic HSCT: new trials by email Literature Review of Allogeneic HSCT trials Research Report on Allogeneic HSCT

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies
Cytarabine, Busulfan, Cyclophosphamide - Leukemia, MDS
Phase 3CompletedFirst Affiliated Hospital of Zhejiang University2322020-09-012026-11-18
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Allogeneic HSCT, Anti-thymocyte globulin (ATG), Cyclosporine (CSP) - Leukemia, Myeloid, Leukemia
Phase 3TerminatedStanford University582007-08-012019-09-24

Conditions studied

Leukemia (2)  ·  Leukemia, Myeloid (1)  ·  Leukemia, Myeloid, Acute (1)

Sponsors

First Affiliated Hospital of Zhejiang University (1)  ·  Stanford University (1)

Countries

China (1)  ·  United States (1)

Top investigators

Robert Lowsky (1)  ·  Yi Luo, MD (1)